Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2026-03-17 @ 3:03 AM
Study NCT ID:
NCT06078306
Status:
UNKNOWN
Last Update Posted:
2024-04-22
First Post:
2023-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
High Risk B-ALL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None